Evaluation of miR-29c inhibits endotheliocyte migration and angiogenesis of human endothelial cells by suppressing the insulin like growth factor 1

American Journal of Translational Research

Volumn 7, Issue 5, 2015, Pages 866-877

  Hu, Yun ^a,b,c   Deng, Feng ^a,b,c   Song, Jinlin ^a,b,c   Lin, Juhong ^a,b,c   Li, Xue ^d   Tang, Yuying ^a,b,c   Zhou, Jie ^a,b,c   Tang, Tian ^e,f   Zheng, Leilei ^a,b,c  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Chongqing key Laboratory of Oral Diseases and Biomedical Sciences   (China)

^c Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education   (China)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e SICHUAN UNIVERSITY   (China)

^f SICHUAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Endothelial Cell; IGF 1; miRNA 29c

Indexed keywords

EID: 84936743673     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. [1] Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, Tsuchihashi T, McManus MT, Schwartz RJ and Srivastava D. Dysregula-tion of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007; 129: 303-317.
2. [2] Li W, Liu M, Feng Y, Xu YF, Huang YF, Che JP, Wang GC, Yao XD and Zheng JH. Downregulat-ed miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1). Br J Cancer 2014; 111: 1188-1200.
3. [3] Wu YH, Hu TF, Chen YC, Tsai YN, Tsai YH, Cheng CC and Wang HW. The manipulation of miRNA-gene regulatory networks by KSHV induces en-dothelial cell motility. Blood 2011; 118: 2896-2905.
4. [4] Pencheva N, Tran H, Buss C, Huh D, Drobnjak M, Busam K and Tavazoie SF. Convergent multi-miRNA targeting of ApoE drives LRP1/ LRP8-dependent melanoma metastasis and angiogenesis. Cell 2012; 151: 1068-1082.
5. [5] Kriegel AJ, Liu Y, Fang Y, Ding X and Liang M. The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury. Physiol Genomics 2012; 44: 237-244.
6. [6] Lew WY, Bayna E, Dalle Molle E, Contu R, Con-dorelli G and Tang T. Myocardial Fibrosis Induced by Exposure to Subclinical Lipopolysac-charide Is Associated with Decreased miR-29c and Enhanced NOX2 Expression in Mice. PLoS One 2014; 9: e107556.
7. [7] Presneau N, Eskandarpour M, Shemais T, Henderson S, Halai D, Tirabosco R and Flanagan AM. MicroRNA profling of peripheral nerve sheath tumours identifes miR-29c as a tumour suppressor gene involved in tumour progression. Br J Cancer 2013; 108: 964-972.
8. [8] Quesada A, Lee BY and Micevych PE. PI3 ki-nase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson’s disease. Dev Neurobiol 2008; 68: 632-644.
9. [9] Perez-Martin M, Cifuentes M, Grondona JM, Bermudez-Silva FJ, Arrabal PM, Perez-Figares JM, Jimenez AJ, Garcia-Segura LM, Fernandez-Llebrez P and Fernandez-Llebrez P. Neurogen-esis in explants from the walls of the lateral ventricle of adult bovine brain: role of endogenous IGF-1 as a survival factor. Eur J Neurosci 2003; 17: 205-211.
10. [10] Chapes SK, Simske SJ, Forsman AD, Bateman TA and Zimmerman RJ. Effects of space fight and IGF-1 on immune function. Adv Space Res 1999; 23: 1955-1964.
11. [11] Zhao P, Turdi S, Dong F, Xiao X, Su G, Zhu X, Scott GI and Ren J. Cardiac-specific overex-pression of insulin-like growth factor I (IGF-1) rescues lipopolysaccharide-induced cardiac dysfunction and activation of stress signaling in murine cardiomyocytes. Shock 2009; 32: 100-107.
12. [12] Corbo M, Lunetta C, Magni P, Dozio E, Ruscica M, Adobbati L and Silani V. Free insulin-like growth factor (IGF)-1 and IGF-binding pro-teins-2 and -3 in serum and cerebrospinal fuid of amyotrophic lateral sclerosis patients. Eur J Neurol 2010; 17: 398-404.
13. [13] De Felice B, Guida M, Guida M, Coppola C, De Mieri G and Cotrufo R. A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. Gene 2012; 508: 35-40.
14. [14] Mehta JL, Mercanti F, Stone A, Wang X, Ding Z, Romeo F and Khaidakov M. Gene and miRNA Transcriptional Signatures of Angiotensin II in Endothelial Cells. J Cardiovasc Pharmacol 2014;
15. [15] White K, Kane NM, Milligan G and Baker AH. The role of miRNA in stem cell pluripotency and commitment to the vascular endothelial lineage. Microcirculation 2012; 19: 196-207.
16. [16] Roy S and Sen CK. miRNA in wound inflammation and angiogenesis. Microcirculation 2012; 19: 224-232.
17. [17] Noman MZ, Buart S, Romero P, Ketari S, Janji B, Mari B, Mami-Chouaib F and Chouaib S. Hy- poxia-inducible miR-210 regulates the suscep tibility of tumor cells to lysis by cytotoxic T cells. Cancer Res 2012; 72: 4629-4641.
18. [18] Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, Harris AL, Gleadle JM and Ra- goussis J. hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 2008; 14: 1340-1348.
19. [19] Yin M, Ren X, Zhang X, Luo Y, Wang G, Huang K, Feng S, Bao X, Huang K, He X, Liang P, Wang Z, Tang H, He J and Zhang B. Selective killing of lung cancer cells by miRNA-506 molecule through inhibiting NF-kappaB p65 to evoke reactive oxygen species generation and p53 activation. Oncogene 2015; 34: 691-703.
20. [20] Wei W, He HB, Zhang WY, Zhang HX, Bai JB, Liu HZ, Cao JH, Chang KC, Li XY and Zhao SH. miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development. Cell Death Dis 2013; 4: e668.
21. [21] Cittelly DM, Finlay-Schultz J, Howe EN, Spoels-tra NS, Axlund SD, Hendricks P, Jacobsen BM, Sartorius CA and Richer JK. Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. Oncogene 2013; 32: 2555-2564.
22. [22] Pekarsky Y and Croce CM. Is miR-29 an onco-gene or tumor suppressor in CLL? Oncotarget 2010; 1: 224-227.
23. [23] Kapinas K, Kessler CB and Delany AM. miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. J Cell Biochem 2009; 108: 216-224.
24. [24] Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, Cervera P and Le Bouc Y. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003; 421: 182-187.
25. [25] Cao P, Maximov A and Sudhof TC. Activity-dependent IGF-1 exocytosis is controlled by the Ca(2+)-sensor synaptotagmin-10. Cell 2011; 145: 300-311.
26. [26] Kornprat P, Rehak P, Ruschoff J and Langner C. Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours. J Clin Pathol 2006; 59: 202-206.
27. [27] Slaaby R, Schaffer L, Lautrup-Larsen I, Andersen AS, Shaw AC, Mathiasen IS and Brandt J. Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant. J Biol Chem 2006; 281: 25869-25874.
28. [28] Karpe PA and Tikoo K. Heat shock prevents insulin resistance-induced vascular complications by augmenting angiotensin-(1-7) signaling. Diabetes 2014; 63: 1124-1139.
29. [29] Vassiliadis E, Barascuk N and Karsdal MA. Ath-erofbrosis - a unique and common process of the disease pathogenesis of atherosclerosis and fbrosis - lessons for biomarker development. Am J Transl Res 2013; 5: 1-14.
30. [30] Gatenby VK and Kearney MT. The role of IGF-1 resistance in obesity and type 2 diabetes-mel-litus-related insulin resistance and vascular disease. Expert Opin Ther Targets 2010; 14: 1333-1342.
31. [31] Toba H, Cortez D, Lindsey ML and Chilton RJ. Applications of miRNA technology for atherosclerosis. Curr Atheroscler Rep 2014; 16: 386.
32. [32] Huang Y, Liu Y, Li L, Su B, Yang L, Fan W, Yin Q, Chen L, Cui T, Zhang J, Lu Y, Cheng J, Fu P and Liu F. Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropa-thy: implications for glomerular endothelial injury. BMC Nephrol 2014; 15: 142.
33. [33] Wang YS, Li SH, Guo J, Mihic A, Wu J, Sun L, Davis K, Weisel RD and Li RK. Role of miR-145 in cardiac myofbroblast differentiation. J Mol Cell Cardiol 2014; 66: 94-105.
34. [34] Gursu EM, Ozdemir A, Yalinbas B, Gursu RU, Canbakan M, Guven B, Atasoyu EM, Keskin AT, Elci A and Baru Y. The effect of icodextrin and glucose-containing solutions on insulin resistance in CAPD patients. Clin Nephrol 2006; 66: 263-268.
35. [35] Banihani SA, Makahleh SM, El-Akawi Z, Al-Fashtaki RA, Khabour OF, Gharibeh MY, Saa-dah NA, Al-Hashimi FH and Al-Khasieb NJ. Fresh pomegranate juice ameliorates insulin resistance, enhances beta-cell function, and decreases fasting serum glucose in type 2 diabetic patients. Nutr Res 2014; 34: 862-7.
36. [36] Garg N, Thakur S, McMahan CA and Adamo ML. High fat diet induced insulin resistance and glucose intolerance are gender-specific in IGF-1R heterozygous mice. Biochem Biophys Res Commun 2011; 413: 476-480.
37. [37] Fan YC, Mei PJ, Chen C, Miao FA, Zhang H and Li ZL. MiR-29c inhibits glioma cell proliferation, migration, invasion and angiogenesis. J Neu-rooncol 2013; 115: 179-188.